Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-γ

Biochemical and Biophysical Research Communications

Volumn 305, Issue 1, 2003, Pages 22-27

  Kageyama, Haruaki ^a   Hirano, Tsutomu ^a   Okada, Kenta ^a   Ebara, Tetsu ^a   Kageyama, Asako ^a   Murakami, Toru ^b   Shioda, Seiji ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Brown adipose tissue deficient mice; Lipoprotein lipase; Pioglitazone; PPAR ; Triglyceride metabolism

Indexed keywords

LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE EXPRESSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

EID: 0038407605     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00663-6     Document Type: Article

References (29)

1. Eckel R.H. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320:1989;1060-1068.
2. Greenwood M.R. The relationship of enzyme activity to feeding behavior in rats: lipoprotein lipase as the metabolic gatekeeper. Int. J. Obes. 9:1985;67-70.
3. Farese R.V. Jr., Yost T.J., Eckel R.H. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism. 40:1991;214-216.
4. Pykalisto O.J., Smith P.H., Brunzell J.D. Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity. J. Clin. Invest. 56:1975;1108-1117.
5. Pollare T., Vessby B., Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler. Thromb. 11:1991;1192-1203.
6. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.M., Heyman R.A., Briggs M., Deeb S., Staels B., Auwerx J. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15:1996;5336-5348.
7. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., Umesono K., Akanuma Y., Fujiwara T., Horikoshi H., Yazaki Y., Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101:1998;1354-1361.
8. Tontonoz P., Hu E., Graves R.A., Budavari A.I., Spiegelman B.M. mPPARγ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1994;1224-1234.
9. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPARγ 2, a lipid-activated transcription factor [published erratum appears in Cell 1995 Mar 24;80(6):following 957]. Cell. 79:1994;1147-1156.
10. Tontonoz P., Hu E., Spiegelman B.M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ Curr. Opin. Genet. Dev. 5:1995;571-576.
11. Vidal-Puig A., Jimenez-Linan M., Lowell B.B., Hamann A., Hu E., Spiegelman B., Flier J.S., Moller D.E. Regulation of PPARγ gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97:1996;2553-2561.
12. Kazumi T., Hirano T., Odaka H., Ebara T., Amano N., Hozumi T., Ishida Y., Yoshino G. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. Diabetes. 45:1996;806-811.
13. Yamazaki Y., Osaka T., Murakami T., Inoue S. JTT-501, a new oral hypoglycemic agent, reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats. Metabolism. 49:2000;574-578.
14. Lowell B.B., S-Susulic V., Hamann A., Lawitts J.A., Himms-Hagen J., Boyer B.B., Kozak L.P., Flier J.S. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 366:1993;740-742.
15. Mantzoros C.S., Frederich R.C., Qu D., Lowell B.B., Maratos-Flier E., Flier J.S. Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations. Diabetes. 47:1998;230-238.
16. Melnyk A., Himms-Hagen J. Temperature-dependent feeding: lack of role for leptin and defect in brown adipose tissue-ablated obese mice. Am. J. Physiol. 274:1998;R1131-R1135.
17. Garruti G., Ricquier D. Analysis of uncoupling protein and its mRNA in adipose tissue deposits of adult humans. Int. J. Obes. Relat. Metab. Disord. 16:1992;383-390.
18. Krauss R.M., Levy R.I., Fredrickson D.S. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J. Clin. Invest. 54:1974;1107-1124.
19. ′ untranslated region of the mRNA Genomics. 11:1991;62-76.
20. Fleury C., Neverova M., Collins S., Raimbault S., Champigny O., Levi-Meyrueis C., Bouillaud F., Seldin M.F., Surwit R.S., Ricquier D., Warden C.H. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 15:1997;269-272.
21. Lee Y., Hirose H., Ohneda M., Johnson J.H., McGarry J.D., Unger R.H. β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc. Natl. Acad. Sci. USA. 91:1994;10878-10882.
22. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 44:1995;863-870.
23. Ferreira L.D., Pulawa L.K., Jensen D.R., Eckel R.H. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes. 50:2001;1064-1068.
24. Kim J.K., Fillmore J.J., Chen Y., Yu C., Moore I.K., Pypaert M., Lutz E.P., Kako Y., Velez-Carrasco W., Goldberg I.J., Breslow J.L., Shulman G.I. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. USA. 98:2001;7522-7527.
25. Voshol P.J., Jong M.C., Dahlmans V.E., Kratky D., Levak-Frank S., Zechner R., Romijn J.A., Havekes L.M. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes. 50:2001;2585-2590.
26. de Souza C.J., Eckhardt M., Gagen K., Dong M., Chen W., Laurent D., Burkey B.F. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes. 50:2001;1863-1871.
27. King A.B., Armstrong D.U. Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review. Diabetes Technol. Ther. 4:2002;145-151.
28. Gimeno R.E., Dembski M., Weng X., Deng N., Shyjan A.W., Gimeno C.J., Iris F., Ellis S.J., Woolf E.A., Tartaglia L.A. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes. 46:1997;900-906.
29. Lapsys N.M., Kriketos A.D., Lim-Fraser M., Poynten A.M., Lowy A., Furler S.M., Chisholm D.J., Cooney G.J. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor γ expression in human skeletal muscle. J. Clin. Endocrinol. Metab. 85:2000;4293-4297.